Cleared Traditional

K201241 - Striate+

K201241 is an FDA 510(k) clearance for Striate+, manufactured by Orthocell, Ltd.. The device is a Class 2 Dental device with product code NPL cleared through the Traditional 510(k) pathway after a 248-day FDA review.

K201241 · Orthocell, Ltd. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
248d
Days
Class 2
Risk

K201241 is an FDA 510(k) clearance for the Striate+™. Classified as Barrier, Animal Source, Intraoral (product code NPL), Class II - Special Controls.

Submitted by Orthocell, Ltd. (Perth, AU). The FDA issued a Cleared decision on January 11, 2021 after a review of 248 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Orthocell, Ltd. devices

FDA 510(k) Submission Details - K201241

510(k) Number K201241 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2020
Decision Date January 11, 2021
Days to Decision 248 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 127d · This submission: 248d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NPL Device Classification - Class 2, Special Controls

Product Code NPL Barrier, Animal Source, Intraoral
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition An Animal Source Dental Barrier Is An Animal-derived Material Device, Such As Collagen, Intended To Aid In Guided Tissue/bone Regeneration Procedures And To Act As A Stable Barrier For The Containment Of Bone Graft Materials When Placed Around Implants.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - NPL Barrier, Animal Source, Intraoral

All 32
Devices cleared under the same product code (NPL) and FDA review panel - the closest regulatory comparables to K201241.
OSSIX Breeze
K212509 · Datum Dental, Ltd. · Jul 2022
Geistlich Bio-Gide, Geistlich Bio-Gide Shape, Geistlich Bio-Gide Compressed, Geistlich Bio-Gide Perio, Geistlich Combi-Kit Collagen and Geistlich Perio-System Combi Pack
K212463 · Geistlich Pharma AG · Apr 2022
Geistlich Mucograft®, Geistlich Mucograft® Seal
K210280 · Geistlich Pharma AG · Mar 2021
Kerecis Gingiva Graft
K192612 · Kerecis Limited · Nov 2020
OssGuide
K200623 · Sk Bioland Co., Ltd. · Oct 2020
Geistlich Bio-Gide, Geistlich Bio-Gide Shape, Geistlich Bio-Gide Compressed, Geistlich Bio-Gide Perio, Geistlich Combi-Kit Collagen, Geistlich Perio-System Combi-Pack, Geistlich Mucograft and Geistlich Mucograft Seal
K192042 · Geistlich Pharma AG · Aug 2019